The impact of a second MRI and re-biopsy in patients with initial negative mpMRI-targeted and systematic biopsy for PIRADS ≥ 3 lesions

OBJECTIVE: To evaluate the proportions of detected prostate cancer (PCa) and clinically significant PCa (csPCa), as well as identify clinical predictors of PCa, in patients with PI-RADS >  = 3 lesion at mpMRI and initial negative targeted and systematic biopsy (initial biopsy) who underwent a sec...

Descripción completa

Detalles Bibliográficos
Autores principales: Zattoni, Fabio, Pereira, Leonor J. Paulino, Marra, Giancarlo, Valerio, Massimo, Olivier, Jonathan, Puche-Sanz, Ignacio, Rajwa, Pawel, Maggi, Martina, Campi, Riccardo, Amparore, Daniele, De Cillis, Sabrina, Junlong, Zhuang, Guo, Hongqian, La Bombarda, Giulia, Fuschi, Andrea, Veccia, Alessandro, Ditonno, Francesco, Marquis, Alessandro, Barletta, Francesco, Leni, Riccardo, Serni, Sergio, Kasivisvanathan, Veeru, Antonelli, Alessandro, Dal Moro, Fabrizio, Rivas, Juan Gomez, van den Bergh, Roderick C. N., Briganti, Alberto, Gandaglia, Giorgio, Novara, Giacomo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Topic Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632220/
https://www.ncbi.nlm.nih.gov/pubmed/37755520
http://dx.doi.org/10.1007/s00345-023-04578-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632220/
https://www.ncbi.nlm.nih.gov/pubmed/37755520
http://dx.doi.org/10.1007/s00345-023-04578-7

Ejemplares similares